Shield Therapeutics Appoints Santosh Shanbhag as New CFO, Effective January 16, 2024
with Akili Inc. as CFO.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 GBX | -7.80% | -19.57% | -71.79% |
May. 28 | NetScientific backs Wanda; Inspirit Energy wins deal | AN |
May. 10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-71.79% | 20.4M | |
+14.29% | 118B | |
+13.81% | 106B | |
-2.55% | 24.28B | |
+0.84% | 21.96B | |
-9.07% | 18.16B | |
-42.12% | 16.37B | |
-17.15% | 15.56B | |
+5.87% | 13.63B | |
+28.84% | 12.27B |